FARALLON CAPITAL MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2021$4,943,000
-18.6%
750,0000.0%0.02%
-33.3%
Q1 2021$6,075,000
-5.8%
750,000
-25.0%
0.03%
-23.1%
Q4 2020$6,450,000
+79.6%
1,000,000
+98.0%
0.04%
+5.4%
Q2 2017$3,591,000505,0000.04%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders